BR100 Decreased By (-0.54%)
BR30 Decreased By (-0.74%)
KSE100 Decreased By (-0.42%)
KSE30 Decreased By (-0.37%)
AGHA 6.62 Decreased By ▼ -0.05 (-0.75%)
BECO 4.39 Increased By ▲ 0.04 (0.92%)
BML 54.95 Decreased By ▼ -1.22 (-2.17%)
BOP 29.93 Decreased By ▼ -0.19 (-0.63%)
CNERGY 12.80 Decreased By ▼ -0.18 (-1.39%)
CSIL 5.20 Decreased By ▼ -0.11 (-2.07%)
FCCL 51.18 Decreased By ▼ -0.47 (-0.91%)
FFL 14.40 Decreased By ▼ -0.09 (-0.62%)
FNEL 1.23 Increased By ▲ 0.02 (1.65%)
KEL 6.03 Decreased By ▼ -0.03 (-0.5%)
KOSM 5.60 Decreased By ▼ -0.24 (-4.11%)
LOTCHEM 26.07 Decreased By ▼ -0.10 (-0.38%)
MLCF 89.90 Decreased By ▼ -1.33 (-1.46%)
NBP 162.53 Decreased By ▼ -1.66 (-1.01%)
NCPL 52.37 Decreased By ▼ -0.81 (-1.52%)
NPL 57.85 Decreased By ▼ -1.27 (-2.15%)
OGDC 313.00 Decreased By ▼ -0.39 (-0.12%)
PACE 9.71 Decreased By ▼ -0.06 (-0.61%)
PAEL 34.90 Decreased By ▼ -0.34 (-0.96%)
PIBTL 14.37 Decreased By ▼ -0.34 (-2.31%)
PPL 219.15 Decreased By ▼ -2.21 (-1%)
PRL 91.60 Increased By ▲ 0.38 (0.42%)
PTC 59.25 Increased By ▲ 0.06 (0.1%)
SSGC 23.37 Increased By ▲ 0.07 (0.3%)
TBL 8.65 Decreased By ▼ -0.10 (-1.14%)
TELE 7.47 Decreased By ▼ -0.14 (-1.84%)
TPL 21.32 Decreased By ▼ -0.71 (-3.22%)
TPLP 12.14 Decreased By ▼ -0.42 (-3.34%)
TREET 21.64 Decreased By ▼ -0.09 (-0.41%)
TRG 55.20 Decreased By ▼ -0.59 (-1.06%)

Citi Pharma Limited, one of Pakistan’s leading pharmaceutical companies, refuted on Thursday reports of it planning to establish a new pharmaceutical manufacturing facility in Iraq.

The company, in a notice to the Pakistan Stock Exchange (PSX), said it had come across social media reports that were circulating regarding the establishment of its new facility.

“The company would like to clarify that following our recent participation in the Iraq Expo, discussions were held at an exploratory level with various stakeholders,” the notice to the bourse read.

The company clarified that no formal decisions, agreements, or commitments have been made to enter into or establish operations in the Iraqi market.

The company has formally requested the concerned platforms to remove these posts to prevent the spread of “inaccurate information”, the pharmaceutical said.

“Citi Pharma Limited remains committed to maintaining transparency and ensuring the timely dissemination of accurate information to its shareholders and the general public in accordance with the applicable regulations.”

Comments

Comments are closed for this article.